Professor, Medicine, Pennsylvania State University College of Medicine

Gastroenterology

Thomas Riley practices Gastroenterology. He researched medicine at The Ohio State University College of Medicine. Dr. Thomas R. Riley III has written publications. He has 24 publications published with PubMed. The lastest paper is: 'Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series.'

Publications

---

• Portal Hypertension: An Underestimated Entity?
• An unusual occurrence of hepatic granulomas and secondary sitosterolemia in turner Syndrome.
• Bedside ultrasound in the diagnosis of nonalcoholic fatty liver Disease.
• Liver transplantation with a strongly positive crossmatch: case study and literature review.
• Impact of geographic disparity on liver allocation for hepatocellular Cancer in the United States.
• Complete Esophageal obstruction following endoscopic variceal ligation.
• Current treatment of choice for chronic hepatitis C infection.
• Immune functional assay for immunosuppressive management in post-transplant malignancy.
• Does weight history affect fibrosis in the setting of chronic liver Disease?
• The effect of processing on liver biopsy core size.
• Long-term treatment with the combination of amantadine and ribavirin in hepatitis C nonresponders. A case series.
• Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver Disease.
• Bedside ultrasound can predict nonalcoholic fatty liver Disease in the hands of clinicians using a prototype image.
• Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver Disease.
• Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver Disease versus other chronic liver Diseases.
• Amantadine therapy for chronic hepatitis C.
• Amantadine therapy for chronic hepatitis C: a dose escalation study.
• Cost-saving approach to patients on long-term anticoagulation who need endoscopy: a decision analysis.
• Preventive strategies in chronic liver disease: part II. Cirrhosis.
• Preventive strategies in chronic liver Disease: part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise.
• Preventive care in chronic liver Disease.
• Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis C: a case series.
• A case series of transplant recipients who despite immunosuppression developed inflammatory bowel Disease.

Schools

---

• Ohio State University College of Medicine

• University of Utah

• University Health Center Of Pittsburgh

• University Of Ut Med Center

• University Of Pittsburgh

Procedures Preformed

---

• Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
• Endoscopy (Esophagus, Stomach, Small Intestine)
• ERCP (Endoscopic Retrograde Cholangiopancreatography)
• Hemorrhoidectomy or Excision of Anal Tags
• View All

Conditions Treated

---

• Abdominal Pain
• Anemia
• Barrett's Esophagus
• Benign Neoplasm of the Digestive System
• View All

Doctors Specialties

---

• Gastroenterology
• Transplant Hepatology

Accepted Insurances

---

Education

---

• University of Pittsburgh Medical Center
• University of Utah
• The Ohio State University College of Medicine

Hospital

---

• Penn State Milton S. Hershey Medical Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Thomas J. McGarrity, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Matthew Moyer, MD This Doctor is OpenDoctor Recommended.
	Dr. Tai-Ping Lee, MD
	Dr. Matthew Nikoloff, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert Werkman, MD This Doctor is OpenDoctor Recommended.
	Dr. Patrick McDevitt, DO
	Dr. Deborah M. Bethards, MD This Doctor is OpenDoctor Recommended.
	Dr. Abraham Mathew, MD This Doctor is OpenDoctor Recommended.
	Dr. Ann Ouyang, MD This Doctor is OpenDoctor Recommended.
	Dr. Nathan Yeasted, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog